Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

Share Price is delayed by 15 minutes
Get Live Data
398.50    3.50 (0.89%)
Bid:
392.00
Ask:
405.00
Spread: 13.00 (3.316%)
Market Cap: £191.27m
TSTL Live PriceLast checked at - London Stock Exchange

Intraday Tristel Share Chart

Director/PDMR Shareholding

12 Nov 2010 10:55

RNS Number : 0907W
Tristel PLC
12 November 2010
 



 

For immediate release

 

TRISTEL plc

Director/PDMR Shareholding

 

Tristel plc ("Tristel" or the "Company"), the infection and contamination control business, was informed yesterday that on 11 November 2010, Mr Antonio Soler, Non-Executive Director , acquired 1,790 ordinary shares of 1p each in the Company at 63.6p per share. Following this transaction and the placing announced on 5 November 2010, A Soler will be interested in 10,000 ordinary shares, representing 0.03% of the enlarged share capital.

 

 

For further information, please contact:

 

Tristel PLC

Paul Swinney, Chief Executive

Tel: 01638 721 500

Walbrook PR Ltd

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

paul.mcmanus@walbrookpr.com

FinnCap

Geoff Nash/Charlotte Stranner (Corporate Finance)

Tel: 020 7600 1658

Simon Starr (Corporate Broking)

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMMMMGZDGGZM
Date   Source Headline
9th Nov 20209:49 amRNSExercise of Options
2nd Nov 202010:30 amRNSQ&A update following preliminary results
27th Oct 20204:50 pmRNSIssue of Equity
19th Oct 20203:15 pmRNSDividend Timetable
19th Oct 20207:00 amRNSFinal Results
6th Oct 20207:00 amRNSNotice of Results
5th Oct 20204:41 pmRNSIssue of Equity
2nd Oct 20209:11 amRNSIssue of Equity
7th Sep 20201:16 pmRNSIssue of Equity
21st Aug 20207:00 amRNSTristel’s Duo for Ultrasound approved in India
7th Aug 202010:46 amRNSIssue of Equity
6th Aug 202010:30 amRNSUpdate from Virtual Shareholder Open Day
22nd Jul 20204:43 pmRNSDirector/PDMR Shareholding and Issue of Equity
22nd Jul 20209:05 amRNSSecond Price Monitoring Extn
22nd Jul 20209:00 amRNSPrice Monitoring Extension
22nd Jul 20207:00 amRNSTrading update
23rd Jun 20207:00 amRNSNotice of Trading update, Results & presentation
8th Jun 202010:40 amRNSIssue of Equity
22nd May 20209:47 amRNSIssue of Equity
28th Apr 20203:40 pmRNSIssue of Equity
27th Apr 20207:00 amRNSDirector Appointment
14th Apr 202010:02 amRNSIssue of Equity
7th Apr 202010:38 amRNSIssue of Equity
31st Mar 20208:00 amRNSHolding(s) in Company
25th Mar 202012:38 pmRNSHolding(s) in Company
23rd Mar 20209:05 amRNSSecond Price Monitoring Extn
23rd Mar 20209:00 amRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSLicense & Product Supply Agreement with Byotrol
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:40 pmRNSPrice Monitoring Extension
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:37 pmRNSPrice Monitoring Extension
13th Mar 20204:14 pmRNSIssue of Equity
10th Mar 202011:56 amRNSIssue of Equity
6th Mar 20201:42 pmRNSHolding(s) in Company
3rd Mar 202010:24 amRNSDirector/PDMR Shareholding and Issue of Equity
26th Feb 20207:00 amRNSHolding(s) in Company
25th Feb 20209:06 amRNSDirector/PDMR Shareholding (Replacement)
25th Feb 20207:00 amRNSDirector/PDMR Shareholding
24th Feb 20207:00 amRNSHalf-year Report
20th Feb 202011:12 amRNSIssue of Equity
18th Feb 20209:51 amRNSIssue of Equity
30th Jan 20203:43 pmRNSIssue of Equity
15th Jan 20207:00 amRNSInvestor results presentation
14th Jan 20201:09 pmRNSIssue of Equity
17th Dec 201911:01 amRNSResult of AGM
17th Dec 20197:00 amRNSAGM Statement and notice of results
4th Dec 20199:30 amRNSIssue of Equity
3rd Dec 201911:20 amRNSHolding(s) in Company
26th Nov 20197:00 amRNSForthcoming Appointment of Non-Executive Chairman

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.